Arvee Laboratories (India) Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: ARVEE | Chemicals | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Arvee Laboratories

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Arvee Laboratories (India) stock performance -

mw4me loader
P/E Ratio (SA):
339.81
Market Cap:
321.1 Cr.
52-wk low:
0
52-wk high:
0

Is Arvee Laboratories (India) Ltd an attractive stock to invest in?

1. Is Arvee Laboratories (India) Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Arvee Laboratories (India) Ltd is a average quality company.

2. Is Arvee Laboratories (India) Ltd undervalued or overvalued?

The key valuation ratios of Arvee Laboratories (India) Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Arvee Laboratories (India) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Arvee Laboratories (India) Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Arvee Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Arvee Laboratories (India) Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 9.6%0.4%9.3%14%11.5%11.4%11%11.7%9.7%12.8%-
Value Creation
Index
-0.3-1.0-0.3-0-0.2-0.2-0.2-0.2-0.3-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 11.81326.834.447.854.945.447.440.361.437
Sales YoY Gr.-9.9%106.8%28.3%38.8%14.9%-17.3%4.3%-14.9%52.1%-
Adj EPS 0-2.80.21.912.122.52.330.9
YoY Gr.--9266.7%NA734.8%-48.4%107.1%-4.4%25%-6.5%31.9%-
BVPS (₹) 5.12.43.35.212.714.816.919.421.725.526.3
Adj Net
Profit
0-1.70.21.61.12.32.22.72.53.31
Cash Flow from Ops. -0.38.66.2469.510.31.742.9-
Debt/CF from Ops. -43.72.44.16.22.71.40.45.20.80.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 20.1%5.1%10.5%52.1%
Adj EPS 66.9%25%15.5%31.9%
BVPS19.6%15%14.6%17.2%
Share Price - 35.8% 50.3% 133.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
1.2-73.69.245.411.814.812.213.411.112.83.3
Op. Profit
Mgn %
15.416.117.516.31511.313.312.81411.99.1
Net Profit
Mgn %
0.2-12.70.74.52.34.14.75.76.35.42.6
Debt to
Equity
4.414.79.661.20.80.20.40.10-
Working Cap
Days
20926618718216714012412316712792
Cash Conv.
Cycle
83132708364533325534364

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 10.54%

Net Profit is growing at healthy rate in last 3 years 15.50%

Return on Equity has declined versus last 3 years average to 3.30%

Sales growth is not so good in last 4 quarters at -43.11%

Latest Financials - Arvee Laboratories (India) Ltd.

Standalone Consolidated
TTM EPS (₹) 0.9 -
TTM Sales (₹ Cr.) 36.8 -
BVPS (₹.) 26.3 -
Reserves (₹ Cr.) 18 -
P/BV 11.08 -
PE 339.81 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 321
Equity (₹ Cr.) 11
Face Value (₹) 10
Industry PE 49.3

Management X-Ray of Arvee Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Arvee Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales12132734485545474061
Operating Expenses 10112229414939413554
Manufacturing Costs1123543335
Material Costs771722303929292239
Employee Cost 1223333666
Other Costs 1111334334
Operating Profit 2256766667
Operating Profit Margin (%) 15.3%16.1%17.5%16.3%15.0%11.2%13.3%12.7%13.9%11.9%
Other Income 0001000111
Interest 2233321100
Depreciation 0112222222
Exceptional Items 0000000000
Profit Before Tax 0-111233436
Tax 010-1101112
Profit After Tax 0-202122334
PAT Margin (%) 0.2%-12.7%0.7%4.5%2.3%4.1%5.1%5.7%6.4%6.7%
Adjusted EPS (₹)0.0-2.80.21.91.02.12.12.42.33.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 3134141619212428
Share Capital 3344666111111
Reserves 0-2-1091113101317
Minority Interest0000000000
Debt1321242415114931
Long Term Debt8151717832111
Short Term Debt5667782820
Trade Payables13661261010108
Others Liabilities 0132331122
Total Liabilities 17263536443734413939

Fixed Assets

Gross Block2101621222224273031
Accumulated Depreciation01247911141618
Net Fixed Assets291317151313141413
CWIP 7540122112
Investments 0000023200
Inventories3676856765
Trade Receivables3268158781212
Cash Equivalents 0111241751
Others Assets2333242217
Total Assets 17263536443734413939

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 09646910243
PBT 0-111233436
Adjustment 2345533222
Changes in Working Capital -261-3-145-3-1-4
Tax Paid 0001-10-1-1-1-2
Cash Flow From Investing Activity -6-6-5-1-1-3-3-10-1
Capex -6-6-5-1-1-2-2-2-2-1
Net Investments 00000-2-1120
Others 0000010100
Cash Flow From Financing Activity 7-2-1-3-4-5-105-6-2
Net Proceeds from Shares 3010900000
Net Proceeds from Borrowing 0003-9-40-1-60
Interest Paid -2-2-3-3-3-1-1000
Dividend Paid 0000000000
Others 501-3-11-960-2
Net Cash Flow 010012-36-2-1
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)1.19-73.589.2445.4112.0114.9713.1713.3811.3615.84
ROCE (%)13.647.5114.3915.1917.6914.115.7915.9913.3323.35
Asset Turnover Ratio0.90.60.880.971.21.351.281.271.011.59
PAT to CFO Conversion(x)N/AN/AN/A264.550.671.330.75
Working Capital Days
Receivable Days67645276917858559173
Inventory Days541319170554245546031
Payable Days579297991118510012115882

Arvee Laboratories (India) Ltd Stock News

Arvee Laboratories (India) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Arvee Laboratories on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Arvee Laboratories stood at ₹321.1.
The latest P/E ratio of Arvee Laboratories as of 01-Jan-1970 05:30 is 339.8.
The latest P/B ratio of Arvee Laboratories as of 01-Jan-1970 05:30 is 11.08.
The 52-week high of Arvee Laboratories is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Arvee Laboratories is ₹36.76 ( Cr.) .

About Arvee Laboratories (India) Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.